{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:12:37Z","timestamp":1792033957601,"version":"4.4.0"},"reference-count":99,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["GA 18-03847S"],"award-info":[{"award-number":["GA 18-03847S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-17-0373 and APVV-18-0302"],"award-info":[{"award-number":["APVV-17-0373 and APVV-18-0302"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2015-1769"],"award-info":[{"award-number":["PICT 2015-1769"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["\u201cFIT\u201d CZ.02.1.01\/0.0\/0.0\/15_003\/0000495"],"award-info":[{"award-number":["\u201cFIT\u201d CZ.02.1.01\/0.0\/0.0\/15_003\/0000495"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006533","name":"Ministerstvo Zem\u011bd\u011blstv\u00ed","doi-asserted-by":"publisher","award":[". RO0518"],"award-info":[{"award-number":[". RO0518"]}],"id":[{"id":"10.13039\/501100006533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>A series of 14 target benzyl [2-(arylsulfamoyl)-1-substituted-ethyl]carbamates was prepared by multi-step synthesis and characterized. All the final compounds were tested for their ability to inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) in vitro, and the selectivity index (SI) was determined. Except for three compounds, all compounds showed strong preferential inhibition of BChE, and nine compounds were even more active than the clinically used rivastigmine. Benzyl {(2S)-1-[(2-methoxybenzyl)sulfamoyl]-4-methylpentan-2-yl}carbamate (5k), benzyl {(2S)-1-[(4-chlorobenzyl)sulfamoyl]-4-methylpentan-2-yl}carbamate (5j), and benzyl [(2S)-1-(benzylsulfamoyl)-4-methylpentan-2-yl]carbamate (5c) showed the highest BChE inhibition (IC50 = 4.33, 6.57, and 8.52 \u00b5M, respectively), indicating that derivatives 5c and 5j had approximately 5-fold higher inhibitory activity against BChE than rivastigmine, and 5k was even 9-fold more effective than rivastigmine. In addition, the selectivity index of 5c and 5j was approx. 10 and that of 5k was even 34. The process of carbamylation and reactivation of BChE was studied for the most active derivatives 5k, 5j. The detailed information about the mode of binding of these compounds to the active site of both BChE and AChE was obtained in a molecular modeling study. In this study, combined techniques (docking, molecular dynamic simulations, and QTAIM (quantum theory of atoms in molecules) calculations) were employed.<\/jats:p>","DOI":"10.3390\/ijms22179447","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T08:42:32Z","timestamp":1630399352000},"page":"9447","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Novel Sulfonamide-Based Carbamates as Selective Inhibitors of BChE"],"prefix":"10.3390","volume":"22","author":[{"given":"Pratibha","family":"Magar","sequence":"first","affiliation":[{"name":"Institute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Parravicini","sequence":"additional","affiliation":[{"name":"Facultad de Qu\u00edmica, Bioqu\u00edmica y Farmacia, Universidad Nacional de San Luis, Instituto Multidisciplinario de Investigaciones Biol\u00f3gicas (IMIBIO-SL), Chacabuco 915, 5700 San Luis, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1969-5258","authenticated-orcid":false,"given":"\u0160\u00e1rka","family":"\u0160t\u011bp\u00e1nkov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6961-6151","authenticated-orcid":false,"given":"Katarina","family":"Svr\u010dkov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana D.","family":"Garro","sequence":"additional","affiliation":[{"name":"Facultad de Qu\u00edmica, Bioqu\u00edmica y Farmacia, Universidad Nacional de San Luis, Instituto Multidisciplinario de Investigaciones Biol\u00f3gicas (IMIBIO-SL), Chacabuco 915, 5700 San Luis, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Jendrzejewska","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, University of Silesia, Szkolna 9, 40007 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pauk","sequence":"additional","affiliation":[{"name":"Institute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0975-1671","authenticated-orcid":false,"given":"Jan","family":"Ho\u0161ek","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296\/70, 621 00 Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2003-9052","authenticated-orcid":false,"given":"Josef","family":"Jamp\u00edlek","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 842 15 Bratislava, Slovakia"},{"name":"Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska Cesta 9, 845 10 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo D.","family":"Enriz","sequence":"additional","affiliation":[{"name":"Facultad de Qu\u00edmica, Bioqu\u00edmica y Farmacia, Universidad Nacional de San Luis, Instituto Multidisciplinario de Investigaciones Biol\u00f3gicas (IMIBIO-SL), Chacabuco 915, 5700 San Luis, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9476-9627","authenticated-orcid":false,"given":"Ale\u0161","family":"Imramovsk\u00fd","sequence":"additional","affiliation":[{"name":"Institute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentska 573, 532 10 Pardubice, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jalz.2019.06.4512","article-title":"Neuropsychiatric and Cognitive Symptoms in Alzheimer\u2019s Disease: A Study in Ad Biomarker Confirmed Patients across the Clinical Spectrum","volume":"15","author":"Eikelboom","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0072-9752(07)01219-5","article-title":"Clinical symptoms in Alzheimer\u2019s disease","volume":"89","author":"Lopez","year":"2008","journal-title":"Handb. Clin. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","article-title":"Neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"7","author":"Lyketsos","year":"2011","journal-title":"Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc."},{"key":"ref_4","unstructured":"Alzheimer\u2019s Association (2020). 2020 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. J. Alzheimer\u2019S Assoc., 16, 391\u2013460."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer\u2019s disease: A review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_6","first-page":"2","article-title":"Revisiting the Cholinergic Hypothesis in Alzheimer\u2019s Disease: Emerging Evidence from Translational and Clinical Research","volume":"6","author":"Hampel","year":"2019","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1192\/bjp.114.512.797","article-title":"The Association between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects","volume":"114","author":"Blessed","year":"1968","journal-title":"Br. J. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.neuron.2018.07.039","article-title":"Tau protein disrupts nucleocytoplasmic transport in Alzheimer\u2019s disease","volume":"99","author":"Eftekharzadeh","year":"2018","journal-title":"Neuron"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3892\/br.2016.630","article-title":"Role of oxidative stress in Alzheimer\u2019s disease","volume":"4","author":"Huang","year":"2016","journal-title":"Biomed. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase Inhibitors: Pharmacology and toxicology","volume":"11","author":"Colovic","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Nordberg, A., Ballard, C., Bullock, R., Darreh-Shori, T., and Somogyi, M. (2013). A Review of Butyrylcholinesterase as a Therapeutic Target in the Treatment of Alzheimer\u2019s Disease. Prim. Care Companion CNS Disord., 15, PCC.12r01412.","DOI":"10.4088\/PCC.12r01412"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2174\/1567205013666160404120542","article-title":"Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer\u2019s Disease","volume":"13","author":"Darvesh","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1185\/03007990152673800","article-title":"A New Therapeutic Target in Alzheimer\u2019s Disease Treatment: Attention to Butyrylcholinesterase","volume":"17","author":"Greig","year":"2001","journal-title":"Curr. Med Res. Opin."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","article-title":"Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer\u2019s disease and type 2 diabetes mellitus","volume":"13","author":"Mushtaq","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0197-0186(92)90189-X","article-title":"Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer\u2019s disease resemble embryonic development\u2014A study of molecular forms","volume":"21","author":"Arendt","year":"1992","journal-title":"Neurochem. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0306-4522(01)00613-3","article-title":"Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine","volume":"110","author":"Mesulam","year":"2002","journal-title":"Neuroscience"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/jpet.107.133330","article-title":"The Butyrylcholinesterase Knockout Mouse as a Model for Human Butyrylcholinesterase Deficiency","volume":"324","author":"Li","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jnnp.2004.039321","article-title":"Rate of Progression of Cognitive Decline in Alzheimer\u2019s Disease: Effect of Butyrylcholinesterase K Gene Variation","volume":"76","author":"Holmes","year":"2005","journal-title":"J. Neurol. Neurosur. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1471-4159.2006.04347.x","article-title":"Excessive Hippocampal Acetylcholine Levels in Acetylcholinesterase-Deficient Mice Are Moderated by Butyrylcholinesterase Activity","volume":"100","author":"Hartmann","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective Butyrylcholinesterase Inhibition Elevates Brain Acetylcholine, Augments Learning and Lowers Alzheimer B-Amyloid Peptide in Rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbr.2011.07.035","article-title":"Butyrylcholinesterase Inhibitors Ameliorate Cognitive Dysfunction Induced by Amyloid-B Peptide in Mice","volume":"225","author":"Alkam","year":"2011","journal-title":"Behav. Brain Res."},{"key":"ref_23","unstructured":"Greig, N.H., Yu, Q., Brossi, A., Soncrant, T.T., and Hausman, M. (2002). Highly Selective Butyrylcholinesterase Inhibitors for the Treatment and Diagnosis of Alzheimer\u2019s Disease and Dementias. (20020094999), U.S. Patent."},{"key":"ref_24","first-page":"433","article-title":"Cholinesterase Inhibitors: New Roles and Therapeutic Alternatives","volume":"50","author":"Giacobini","year":"2004","journal-title":"J. Ital. Pharmacol. Soc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2125.1999.00026.x","article-title":"Acetylcholinesterase Inhibitors in Alzheimer\u2019s Disease","volume":"48","author":"McGleenon","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1567205054367838","article-title":"Cholinesterases: Roles in the Brain During Health and Disease","volume":"2","author":"Ballard","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/CIA.S129145","article-title":"Rivastigmine: The advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson\u2019s disease dementia","volume":"12","author":"Kandiah","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"30971","DOI":"10.1021\/acsomega.0c03848","article-title":"Structure-based scaffold repurposing toward the discovery of novel cholinesterase inhibitors","volume":"5","author":"Dighe","year":"2020","journal-title":"ACS Omega"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145705005833","article-title":"Targeting acetylcholinesterase and butyrylcholinesterase in dementia","volume":"9","author":"Lane","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00365510260296564","article-title":"Butyrylcholinesterase Activity and Risk Factors for Coronary Artery Disease","volume":"62","author":"Alcantara","year":"2002","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.clinbiochem.2011.03.028","article-title":"Butyrylcholinesterase Activity in Young Men and Women: Association with Cardiovascular Risk Factors","volume":"44","author":"Stojanov","year":"2011","journal-title":"Clin. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2169\/internalmedicine.46.0049","article-title":"Serum Butyrylcholinesterase is Strongly Associated with Adiposity, the Serum Lipid Profile and Insulin Resistance","volume":"46","author":"Iwasaki","year":"2007","journal-title":"Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/cen.12171","article-title":"Serum Butyrylcholinesterase and the Risk of Future Type 2 Diabetes: The Kansai Healthcare Study","volume":"80","author":"Sato","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cbi.2008.03.009","article-title":"The Butyrylcholinesterase Knockout Mouse is Obese on a High-Fat Diet","volume":"175","author":"Li","year":"2008","journal-title":"Chem.-Biol. Interact."},{"key":"ref_35","first-page":"1479","article-title":"Cholinesterase inhibitors as Alzheimer\u2019s therapeutics","volume":"20","author":"Sharma","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1021\/jm501195e","article-title":"Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor","volume":"57","author":"Brus","year":"2014","journal-title":"Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1021\/acs.jmedchem.5b01674","article-title":"Discovery of highly selective and nanomolar carbamate-based butyrylcholinesterase inhibitors by rational investigation into their inhibition mode","volume":"59","author":"Sawatzky","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1038\/s41598-018-22747-2","article-title":"Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer\u2019s disease","volume":"8","author":"Kumar","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"102949","DOI":"10.1016\/j.bioorg.2019.102949","article-title":"Highly selective carbamate-based butyrylcholinesterase inhibitors derived from a naturally occurring pyranoisoflavone","volume":"88","author":"Wu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.jmedchem.9b01012","article-title":"Highly selective butyrylcholinesterase inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an Alzheimer\u2019s disease mouse model","volume":"62","author":"Hoffmann","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Bak, A., Kozik, V., Kozakiewicz, D., Gajcy, K., Strub, D.J., Swietlicka, A., Stepankova, S., Imramovsky, A., Polanski, J., and Smolinski, A. (2019). Novel benzene-based carbamates for AChE\/BChE inhibition: Synthesis and ligand\/structure-oriented SAR study. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20071524"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"105776","DOI":"10.1016\/j.jsbmb.2020.105776","article-title":"The synthesis and cholinesterase inhibitory activities of solasodine analogues with seven-membered F ring","volume":"205","author":"Kielczewska","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2165\/00003088-200241100-00003","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Cholinesterase Inhibitors","volume":"41","author":"Jann","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.chroma.2006.11.029","article-title":"Characterization of reversible and pseudo-irreversible acetylcholinesterase inhibitors by means of an immobilized enzyme reactor","volume":"1144","author":"Bartolini","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0021-9258(18)64619-8","article-title":"Carbamylation of Acetylcholinesterase","volume":"235","author":"Wilson","year":"1960","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0021-9258(18)64204-8","article-title":"Carbamyl derivatives of acetylcholinesterase","volume":"236","author":"Wilson","year":"1961","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/14756366.2016.1265521","article-title":"Pharmacophore-based design and discovery of (\u2212)-meptazinol carbamates as dual modulators of cholinesterase and amyloidogenesis","volume":"32","author":"Xie","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1021\/bi020016x","article-title":"Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine","volume":"41","author":"Millard","year":"2002","journal-title":"Biochemistry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"103627","DOI":"10.1016\/j.bioorg.2020.103627","article-title":"Synthesis, structure elucidation, and in vitro pharmacological evaluation of novel polyfluoro substituted pyrazoline type sulfonamides as multi-target agents for inhibition of acetylcholinesterase and carbonic anhydrase I and II enzymes","volume":"96","author":"Yamali","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.bmcl.2014.12.006","article-title":"Sulfonamides as multifunctional agents for Alzheimer\u2019s disease","volume":"25","author":"Bag","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"39495","DOI":"10.1038\/srep39495","article-title":"Development of an in-vivo active reversible butyrylcholinesterase inhibitor","volume":"6","author":"Brus","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"10142","DOI":"10.3390\/molecules170910142","article-title":"Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking","volume":"17","author":"Imramovsky","year":"2012","journal-title":"Molecules"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.bmc.2013.01.052","article-title":"Synthesis and in vitro evaluation of new derivatives of 2-substituted-6-fluorobenzo[d]thiazoles as cholinesterase inhibitors","volume":"21","author":"Imramovsky","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1021\/ar00109a003","article-title":"Atoms in molecules","volume":"18","author":"Bader","year":"1985","journal-title":"Acc. Chem. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0040-4039(00)92121-X","article-title":"A facile synthesis of chiral of chiral N-protected \u03b2-amino alcohols","volume":"32","author":"Rodriguez","year":"1991","journal-title":"Tet. Lett."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"11969","DOI":"10.1002\/anie.201406964","article-title":"M. Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active site","volume":"53","author":"Dubiella","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"ref_58","unstructured":"(2021, June 19). DrugBank\u2014Rivastigmine. Available online: https:\/\/go.drugbank.com\/drugs\/DB00989."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3350095","article-title":"The \u2018aromatic patch\u2019 of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors","volume":"335","author":"Ariel","year":"1998","journal-title":"Biochem. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"112792","DOI":"10.1016\/j.ejmech.2020.112792","article-title":"Combined MD\/QTAIM techniques to evaluate ligand-receptor interactions. Scope and limitations","volume":"208","author":"Rojas","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"104145","DOI":"10.1016\/j.bioorg.2020.104145","article-title":"Hydroxynaphthalenecarboxamides and Substituted Piperazinylpropandiols, Two New Series of BRAF Inhibitors. A theoretical and experimental study","volume":"103","author":"Campos","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"103414","DOI":"10.1016\/j.bioorg.2019.103414","article-title":"Design of new quinolin-2-one-pyrimidine hybrids as sphingosine kinases inhibitors","volume":"94","author":"Vettorazzi","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ejmech.2017.08.017","article-title":"An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors","volume":"139","author":"Vettorazzi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1021\/ci400178h","article-title":"Molecular modeling study of dihydrofolate reductase inhibitors. Molecular dynamics simulations, quantum mechanical calculations, and experimental corroboration","volume":"53","author":"Tosso","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Padrtova, T., Marvanova, P., Odehnalova, K., Kubinova, R., Parravicini, O., Garro, A., Enriz, R., Humpa, O., Oravec, M., and Mokry, P. (2017). Synthesis, analysis, cholinesterase-inhibiting activity and molecular modelling studies of 3-(dialkylamino)-2-hydroxypropyl 4-[(alkoxy-carbonyl)amino]benzoates and their quaternary ammonium salts. Molecules, 22.","DOI":"10.3390\/molecules22122048"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Parravicini, O., Angelina, E., Spinelli, R., Garibotto, F., Siano, A.S., Vila, L., Cabedo, N., Cortes, D., and Enriz, R.D. (2021). Design, synthesis, biological evaluation and molecular modelling of substituted pyrrolo[2,1-a]isoquinolinone derivatives: Discovery of potent inhibitors of AChE and BChE. New J. Chem., in press.","DOI":"10.1039\/D1NJ00345C"},{"key":"ref_68","unstructured":"(2021, June 19). DrugBank\u2014Galantamine. Available online: https:\/\/go.drugbank.com\/drugs\/DB00674."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.phymed.2017.12.020","article-title":"Cholinesterase-inhibitory effect and in silico analysis of alkaloids from bulbs of hieronymiella species","volume":"39","author":"Ortiz","year":"2018","journal-title":"Phytomedicine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acs.jnatprod.5b00785","article-title":"Alkaloids from hippeastrum argentinum and their cholinesterase-inhibitory activities: An in vitro and in silico study","volume":"79","author":"Ortiz","year":"2016","journal-title":"J. Nat. Prod."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0014-5793(99)01637-3","article-title":"Structure of acetylcholinesterase complexed with (\u2212)-galanthamine at 2.3 \u00c5 resolution","volume":"463","author":"Greenblatt","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9466","DOI":"10.1039\/D0NJ00282H","article-title":"Synthesis, biological evaluation and molecular modeling studies of substituted N-benzyl-2-phenylethanamines as cholinesterase inhibitors","volume":"44","author":"Parravicini","year":"2020","journal-title":"New J. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1678899","article-title":"Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein","volume":"253","author":"Sussman","year":"1991","journal-title":"Science"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1073\/pnas.87.19.7546","article-title":"Mutagenesis of essential functional residues in acetylcholinesterase","volume":"87","author":"Gibney","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1096\/fasebj.7.14.8224608","article-title":"Noncholinergic functions of cholinesterases","volume":"7","author":"Balasubramanian","year":"1993","journal-title":"FASEB J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modeling: Towards prediction paradise?","volume":"2","author":"Gifford","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Kerns, E.H., and Di, L. (2008). Drug-Like Properties: Concepts. Structure Design and Methods: From ADME to Toxicity Optimization, Academic Press.","DOI":"10.1016\/B978-012369520-8.50018-8"},{"key":"ref_79","unstructured":"Wermuth, C., Aldous, D., Raboisson, P., and Rognan, D. (2015). The Practice of Medicinal Chemistry, Academic Press. [4th ed.]."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1021\/ci200035q","article-title":"Definition of drug-likeness for compound affinity","volume":"51","author":"Fukunishi","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17460441.2016.1110142","article-title":"Potential of agricultural fungicides for antifungal drug discovery","volume":"11","author":"Jampilek","year":"2016","journal-title":"Expert Opin. Drug Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: The rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.foodchem.2004.05.001","article-title":"An improved method to determine SH and \u2013S\u2013S\u2013 group content in soymilk protein","volume":"88","author":"Ou","year":"2004","journal-title":"Food Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/BJ20090091","article-title":"Structure\u2013activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun","volume":"421","author":"Carletti","year":"2009","journal-title":"Biochem. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bioorg.2014.11.005","article-title":"Salicylanilide diethyl phosphates as cholinesterases inhibitors","volume":"58","year":"2015","journal-title":"Bioorg. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_89","unstructured":"Case, D.A., Betz, R.M., Cerutti, D.S., Cheatham, T.E., Darden, T.A., Duke, R.E., Giese, T.J., Gohlke, H., Goetz, A.W., and Homeyer, N. (2016). AMBER 2016, University of California."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Piana","year":"2010","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1063\/1.1332996","article-title":"Langevin stabilization of molecular dynamics","volume":"114","author":"Izaguirre","year":"2001","journal-title":"J. Chem. Phys."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Comput. Phys."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"ref_97","unstructured":"Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Petersson, G.A., and Nakatsuji, H. (2016). Gaussian 16, Revision C.01, Gaussian, Inc."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: A multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Kos, J., Kozik, V., Pindjakova, D., Jankech, T., Smolinski, A., Stepankova, S., Hosek, J., Oravec, M., Jampilek, J., and Bak, A. (2021). Synthesis and Hybrid SAR Property Modeling of Novel Cholinesterase Inhibitors. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073444"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/17\/9447\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:53:08Z","timestamp":1760165588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/17\/9447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":99,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["ijms22179447"],"URL":"https:\/\/doi.org\/10.3390\/ijms22179447","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,31]]}}}